Medicenter Nowy Targ

Nowy Targ 34-400

0 studies enrolling now · 2 studies all time

What they study most

Ulcerative Colitis

Studies at this site

• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed